Top Institutions in Dermatology
Institutions were ranked based on their leadership in dermatology clinical research, guideline development, and contributions to pivotal trials in acne, atopic dermatitis, and psoriasis, including expertise in biologics, JAK inhibitors, and validated severity instruments.
-
#1
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
Home to the Department of Dermatology with extensive research in psoriasis and atopic dermatitis, leading multiple pivotal clinical trials including biologics and JAK inhibitors, and active contributors to guideline development.
Key Differentiators
- Dermatology
- Clinical Trials
- Immunodermatology
-
#2
Harvard Medical School / Massachusetts General Hospital Dermatology
Boston, MA
Renowned for translational dermatology research, extensive involvement in clinical trials for acne, psoriasis, and atopic dermatitis, and leadership in evidence-based dermatology guideline formulation.
Key Differentiators
- Dermatology
- Clinical Research
- Translational Medicine
-
#3
Stanford University School of Medicine Dermatology
Stanford, CA
Leads innovative clinical trials in biologics and small molecule therapies for psoriasis and atopic dermatitis, with a strong emphasis on patient-centered outcomes and severity instrument development.
Key Differentiators
- Dermatology
- Clinical Trials
- Biologic Therapies
-
#4
Johns Hopkins University School of Medicine Dermatology
Baltimore, MD
Strong clinical research programs in inflammatory skin diseases including atopic dermatitis and psoriasis, with significant contributions to clinical guidelines and therapeutic innovations.
Key Differentiators
- Dermatology
- Clinical Trials
- Inflammatory Skin Diseases
-
#5
University of California, San Francisco (UCSF) Dermatology
San Francisco, CA
Known for comprehensive psoriasis research programs, involvement in multi-center clinical trials, and contributions to evidence-based treatment guidelines and severity assessment tools.
Key Differentiators
- Dermatology
- Clinical Trials
- Psoriasis Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
